-+ 0.00%
-+ 0.00%
-+ 0.00%

MESOBLAST RECEIVES BLA FILING NUMBER AND REQUESTS MODULAR REVIEW FOR REXLEMESTROCEL-L IN PATIENTS WITH END-STAGE HEART FAILURE AND LVADS

Reuters·07/01/2026 00:38:30

Please log in to view news